A Phase 3 randomized, open-label, active-controlled, par

Project: Research project

Project Details

Description

A Phase 3 randomized, open-label, active-controlled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of GSK1278863 compared to darbepoetin al
StatusActive
Effective start/end date10/1/1612/31/24

Funding

  • GlaxoSmithKline

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.